Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb 6;290(6):3440-54.
doi: 10.1074/jbc.M114.611608. Epub 2014 Dec 1.

Fusidic acid targets elongation factor G in several stages of translocation on the bacterial ribosome

Affiliations

Fusidic acid targets elongation factor G in several stages of translocation on the bacterial ribosome

Anneli Borg et al. J Biol Chem. .

Abstract

The antibiotic fusidic acid (FA) targets elongation factor G (EF-G) and inhibits ribosomal peptide elongation and ribosome recycling, but deeper mechanistic aspects of FA action have remained unknown. Using quench flow and stopped flow experiments in a biochemical system for protein synthesis and taking advantage of separate time scales for inhibited (10 s) and uninhibited (100 ms) elongation cycles, a detailed kinetic model of FA action was obtained. FA targets EF-G at an early stage in the translocation process (I), which proceeds unhindered by the presence of the drug to a later stage (II), where the ribosome stalls. Stalling may also occur at a third stage of translocation (III), just before release of EF-G from the post-translocation ribosome. We show that FA is a strong elongation inhibitor (K50% ≈ 1 μm), discuss the identity of the FA targeted states, and place existing cryo-EM and crystal structures in their functional context.

Keywords: Antibiotic Action; Elongation Factor G; Fusidic Acid; Kinetics; Protein Synthesis; Slow Inhibitors; Translation Elongation Factor; Translocation.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
General scheme for peptide elongation cycle “i” during ribosomal synthesis of a protein and its inhibition by FA. In the special case that i = 1, Fig. 1 describes the first elongation cycle in the synthesis of a protein, as in Fig. 4. The scheme contains parameters obtainable from the present experiments, also relevant for FA inhibition of protein synthesis in the living cell. Subscheme A shows the inhibition of peptide bond formation by EF-G and FA.
FIGURE 2.
FIGURE 2.
Dipeptide formation after preincubation of initiation complexes with EF-G and FA. A, time traces for dipeptide formation obtained after preincubation of initiation complexes (1 μm) with EF-G(GDP) (20 μm) and FA at varying concentration and subsequent mixing with EF-Tu(GTP)·Leu-tRNALeu ternary complexes (2 μm). B, fraction of ribosomes bound in EF-G·FA complexes as a function of FA concentration in the presence of GDP (black trace) or GTP (purple trace). C, variation in the time of release of FA from the complex at 20 and 5 μm EF-G (slow phase in Fig. 2A). D, total time of dipeptide formation as a function of the FA concentration at 5 and 20 μm EF-G. E, schematic of dipeptide formation in the presence of EF-G and FA. Upon preincubation with FA and EF-G, the initiation complexes partitioned between the free state (R1) and the EF-G- and FA-bound state RI30. EF-G binds to the initiated ribosome R1 with rate constant kG30 to form RG30, from which it dissociates with rate constant qG30. FA binds to RG30 with rate constant kF30 to form RI30, from which it dissociates slowly with rate constant qF30. Upon mixing of the pre-equilibrated reaction mixture with ternary complex, the free initiation complexes, R1, rapidly form dipeptide, whereas the bound ribosomes slowly release FA before they can bind ternary complex and form dipeptide. Error bars, S.E.
FIGURE 3.
FIGURE 3.
Dipeptide formation in the absence of preincubation of initiation complexes with EF-G and FA. Time traces were obtained after mixing of initiated ribosomes (0.5 μm) with EF-G (20 μm) and EF-Tu(GDP)·tRNALeu ternary complexes (1 (circles) or 2 μm (squares)) in the presence (2 mm; red traces) or absence (black traces) of FA. (The concentrations are the effective concentrations after mixing.)
FIGURE 4.
FIGURE 4.
Schematic of FA inhibition of the first peptide elongation steps (see also Fig. 1). The FA inhibition modes I, II, and III (IIIA and IIIB) are enclosed in red boxes. The 70S initiation complex (R1) with fMet-tRNAfMet in the P site may bind ternary complex and form ribosomal complex Rpep1 by peptide bond formation. Alternatively, EF-G may bind to R1 with the rate constant kG30 and form complex RG30, from which EF-G dissociates with the rate constant qG30. FA may bind to RG30 with the rate constant kF30 to form the stable complex RI30, from which it slowly dissociates with the rate constant qF30. These reactions define the third inhibition mode of FA (III). Ribosomal complex Rpep1 may, via the complexes RG01, RG11, RG21, and RG31, be rapidly translocated by EF-G to ribosomal complex R2 with Michaelis-Menten parameters kG1 and KG1. Alternatively, FA may bind to RG11 with association rate constant kF11 and form RI11, which is rapidly transformed to RI21 in which the ribosome is stalled until FA release with rate constant qF21. After this, FA may rebind to RG21, or the reaction may continue downstream to the post-translocation state RG31 with the rate constant kG21. The post-translocation state may inefficiently bind FA with rate constant kF31 or release EF-G with rate constant qG31. The first binding of FA to the translocating ribosome with rate constant kF11 and subsequent dissociation of FA from RI21 define the first and strongest mode of action of FA. After the first FA dissociation from RI21, multiple rebinding of FA to RG21 defines the second inhibition mode of FA.
FIGURE 5.
FIGURE 5.
Single round tripeptide formation. A, time traces for tripeptide formation in the presence of varying concentrations of FA and 20 μm EF-G. B, the fraction of ribosomes bound by FA during single turnover tripeptide formation plotted as a function of FA concentration. C, variation in the average time of release of the FA complex in presence of 20 (black) or 5 μm (green) EF-G compared with the average time of release from the post-translocation complex (RI31) measured in a separate set of experiments (purple). D, total time of tripeptide formation as a function of the FA concentration in the presence of 20 or 5 μm EF-G. Error bars, S.E.
FIGURE 6.
FIGURE 6.
A, translocation of mRNA monitored with fluorescent 3′-pyrene labeled mRNA at 20 μm EF-G and varying FA concentration. From fluorescence time traces F[FA](t), where F is fluorescence intensity, [FA] is fusidic acid concentration, and t is incubation time, normalized intensity ratios Δ[FA](t) = (F[FA](t) − F0(∞))/(F0(0) − F0(∞)) were formed. Final time was defined as the time at which the mRNA movement had been completed. The intensity ratio at final time is given by Δ[FA](∞) = (F[FA](∞) − F0(∞))/(F0(0) − F0(∞)). By definition, it was zero in the absence of FA and increased with increasing FA concentration due to increasing values of F[FA](∞). Solid lines, double exponential functions fitted to Δ[FA](t). A digital filter was used to reduce the noise and the number of data points in the traces. B, the intensity ratio Δ[FA](∞) and the fraction of FA-bound ribosomes estimated from tripeptide experiments (Fig. 5B) were plotted as functions of the FA concentration. The Δ[FA](∞) values were normalized for correspondence with quench flow data at 400 μm FA. Solid lines, hyperbolic functions fitted to both data series. Error bars, S.E.
FIGURE 7.
FIGURE 7.
Cycling of EF-G in multiple turnover translocation. A small amount of EF-G (0.05 μm) was allowed to cycle on in situ-formed pretranslocation complexes (2 μm) translocating the fMet-Leu dipeptidyl-tRNA into the ribosomal P site enabling formation of fMet-Leu-Phe tripeptide. Tripeptide formation was followed over time in the absence (black trace) or presence of FA (20 μm; gray trace).

Similar articles

Cited by

References

    1. Yonath A. (2005) Antibiotics targeting ribosomes: resistance, selectivity, synergism and cellular regulation. Annu. Rev. Biochem. 74, 649–679 - PubMed
    1. Wilson D. N. (2014) Ribosome-targeting antibiotics and mechanisms of bacterial resistance. Nat. Rev. Microbiol. 12, 35–48 - PubMed
    1. Willie G. R., Richman N., Godtfredsen W. P., Bodley J. W. (1975) Some characteristics of and structural requirements for the interaction of 24,25-dihydrofusidic acid with ribosome-elongation factor G complexes. Biochemistry 14, 1713–1718 - PubMed
    1. Okura A., Kinoshita T., Tanaka N. (1971) Formation of fusidic acid-G factor-GDP-ribosome complex and the relationship to the inhibition of GTP hydrolysis. J. Antibiot. 24, 655–661 - PubMed
    1. Hirashima A., Kaji A. (1973) Role of elongation factor G and a protein factor on the release of ribosomes from messenger ribonucleic acid. J. Biol. Chem. 248, 7580–7587 - PubMed

Publication types

MeSH terms